Matches in Wikidata for { <http://www.wikidata.org/entity/Q92726548> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- Q92726548 description "artículu científicu espublizáu n'agostu de 2019" @default.
- Q92726548 description "im August 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q92726548 description "scientific article published on 20 August 2019" @default.
- Q92726548 description "wetenschappelijk artikel" @default.
- Q92726548 description "наукова стаття, опублікована 20 серпня 2019" @default.
- Q92726548 name "Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml" @default.
- Q92726548 name "Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml" @default.
- Q92726548 type Item @default.
- Q92726548 label "Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml" @default.
- Q92726548 label "Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml" @default.
- Q92726548 prefLabel "Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml" @default.
- Q92726548 prefLabel "Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml" @default.
- Q92726548 P1433 Q92726548-15B6D8D0-B274-4B30-AB9E-B4C7A7B68711 @default.
- Q92726548 P1476 Q92726548-44C91DF2-87C5-4961-8238-6BACE363DFA9 @default.
- Q92726548 P2093 Q92726548-0091E8C6-16BA-416C-8682-56F1B1557964 @default.
- Q92726548 P2093 Q92726548-1732745E-0F06-49A8-B873-11506FF255B3 @default.
- Q92726548 P2093 Q92726548-4CC48545-3180-4062-957F-E182B22067C5 @default.
- Q92726548 P2093 Q92726548-57B3F324-B2A8-4236-8599-0094C8A7C4FD @default.
- Q92726548 P2093 Q92726548-616683D4-BE19-4E6A-A1B8-F326C4DDFB66 @default.
- Q92726548 P2093 Q92726548-6A4819FC-5313-4304-BE3E-B099E3EADDE5 @default.
- Q92726548 P2093 Q92726548-6BC2106A-8A40-4285-A1E1-37E4D8D5F335 @default.
- Q92726548 P2093 Q92726548-72F6A3F4-E2B6-45F2-97E6-D16EB1BC551E @default.
- Q92726548 P2093 Q92726548-8CB7EE0E-4232-4318-860C-56FD5E929A6E @default.
- Q92726548 P2093 Q92726548-8EF9008C-FF52-4EE1-A578-91B081A2FCEE @default.
- Q92726548 P2093 Q92726548-9CACD8F5-9208-4B0C-86B4-5083E24A1754 @default.
- Q92726548 P2093 Q92726548-A7ABB1D6-4BFD-4AD0-94A7-21552CB28706 @default.
- Q92726548 P2093 Q92726548-CDDF6B4C-EDF0-4A58-A4E6-29421A5B9ED3 @default.
- Q92726548 P2093 Q92726548-E63B374F-2E4C-4C28-8655-3A27223EF170 @default.
- Q92726548 P2093 Q92726548-E6F0218A-17E7-465E-9619-08CFF357740A @default.
- Q92726548 P2093 Q92726548-E870AEA4-2A03-4C92-B093-3EA3DE6AD57C @default.
- Q92726548 P2093 Q92726548-F400895B-C545-4540-86AC-FD9C3E8FAE31 @default.
- Q92726548 P304 Q92726548-9CB68C25-A7BC-46BD-AD52-AD8ECAE44384 @default.
- Q92726548 P31 Q92726548-4AA10438-7353-4CC2-A737-0795E968E433 @default.
- Q92726548 P356 Q92726548-6C613CD8-BEA4-48E7-AF2C-3788C95DAE42 @default.
- Q92726548 P433 Q92726548-27F86CA7-5032-4731-861A-E16126134D99 @default.
- Q92726548 P478 Q92726548-E19EC350-BABA-4D6D-B855-9A22F5957698 @default.
- Q92726548 P50 Q92726548-05899E91-69EC-4BEC-90AC-969FED5BAA72 @default.
- Q92726548 P577 Q92726548-A581DA1E-2955-4923-82EA-17904748792A @default.
- Q92726548 P698 Q92726548-14F5CE77-2378-4D23-9501-6155F5008DAC @default.
- Q92726548 P356 JU.0000000000000495 @default.
- Q92726548 P698 31430244 @default.
- Q92726548 P1433 Q15709979 @default.
- Q92726548 P1476 "Diagnostic Impacts of Clinical Laboratory Based p2PSA Indexes on any Grade, Gleason Grade Group 2 or Greater, or 3 or Greater Prostate Cancer and Prostate Specific Antigen below 10 ng/ml" @default.
- Q92726548 P2093 "Akiko Ouraji" @default.
- Q92726548 P2093 "Akira Yokomizo" @default.
- Q92726548 P2093 "Eiji Kashiwagi" @default.
- Q92726548 P2093 "Gaku Arai" @default.
- Q92726548 P2093 "Hiroji Uemura" @default.
- Q92726548 P2093 "Hiroki Kitoh" @default.
- Q92726548 P2093 "Hiromi Hirama" @default.
- Q92726548 P2093 "Hisashi Hasumi" @default.
- Q92726548 P2093 "Kazuhiro Suzuki" @default.
- Q92726548 P2093 "Kazuto Ito" @default.
- Q92726548 P2093 "Koichiro Akakura" @default.
- Q92726548 P2093 "Members of PROPHET" @default.
- Q92726548 P2093 "Mikio Sugimoto" @default.
- Q92726548 P2093 "Ryo Oki" @default.
- Q92726548 P2093 "Shoji Tokunaga" @default.
- Q92726548 P2093 "Tomoaki Hakariya" @default.
- Q92726548 P2093 "Yoshitomo Kobori" @default.
- Q92726548 P304 "83-91" @default.
- Q92726548 P31 Q13442814 @default.
- Q92726548 P356 "10.1097/JU.0000000000000495" @default.
- Q92726548 P433 "1" @default.
- Q92726548 P478 "203" @default.
- Q92726548 P50 Q117268440 @default.
- Q92726548 P577 "2019-08-20T00:00:00Z" @default.
- Q92726548 P698 "31430244" @default.